Costello Asset Management, Inc Uro Gen Pharma Ltd. Transaction History
Costello Asset Management, Inc
- $260 Million
- Q2 2025
A detailed history of Costello Asset Management, Inc transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Costello Asset Management, Inc holds 200 shares of URGN stock, worth $4,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$4,050
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
163Shares Held
39.6MCall Options Held
2.06MPut Options Held
717K-
Rtw Investments, LP New York, NY4.54MShares$92 Million0.96% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$64.6 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.48MShares$50.2 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$44.5 Million0.27% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$44.4 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $460M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...